911658

Pomalidomide-C3-NH2 hydrochloride

≥95%

Manufacturer: Sigma Aldrich

Synonym(S): 4-((3-Aminopropyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride, Crosslinker−E3 ligase ligand conjugate, Pomalidomide conjugate, Protein degrader building block for PROTAC® research, Template for synthesis of targeted protein degrader

Select a Size

Pack Size SKU Availability Price
50 MG 911658-50-MG In Stock ₹ 22,950.00

911658 - 50 MG

₹ 22,950.00

In Stock

Quantity

1

Base Price: ₹ 22,950.00

GST (18%): ₹ 4,131.00

Total Price: ₹ 27,081.00

ligand

pomalidomide

Assay

≥95%

form

powder

reaction suitability

reactivity: carboxyl reactivereagent type: ligand-linker conjugate

functional group

amine

storage temp.

2-8°C

SMILES string

O=C(C(CC1)N(C2=O)C(C3=C2C=CC=C3NCCCN)=O)NC1=O.Cl

Related Products

Img

Sigma Aldrich

911666

≥95%...

Img

Sigma Aldrich

901831

--

Img

Sigma Aldrich

901832

≥98%...

Img

Sigma Aldrich

901516

≥95%...

Img

Sigma Aldrich

901513

≥95%...

Img

Sigma Aldrich

901495

≥95%...

Img

Sigma Aldrich

905224

≥95%...

Img

Sigma Aldrich

911739

≥95%...

Description

  • Application: Protein degrader building block Pomalidomide-C3-NH2 hydrochloride enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology. This conjugate contains a Cereblon (CRBN)-recruiting ligand and an alkyl-chain crosslinker with pendant amine for reactivity with an acid on the target ligand. Because even slight alterations in ligands and crosslinkers can affect ternary complex formation between the target, E3 ligase, and PROTAC, many analogs are prepared to screen for optimal target degradation. When used with other protein degrader building blocks with a terminal amine, parallel synthesis can be used to more quickly generate PROTAC libraries that feature variation in crosslinker length, composition, and E3 ligase ligand.
  • Other Notes: Technology Spotlight: Degrader Building Blocks for Targeted Protein DegradationPortal: Building PROTAC® Degraders for Targeted Protein Degradation
  • Legal Information: PROTAC is a registered trademark of Arvinas Operations, Inc., and is used under license

SAFETY INFORMATION

Pictograms

GHS08

Signal Word

Danger

Hazard Statements

H360D

Precautionary Statements

P201 - P202 - P280 - P308 + P313 - P405 - P501

Hazard Classifications

Repr. 1B

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Compare Similar Items

Show Difference

Img

Sigma Aldrich

911658

≥95%...


ligand:
pomalidomide

Assay:
≥95%

form:
powder

reaction suitability:
reactivity: carboxyl reactivereagent type: ligand-linker conjugate

functional group:
amine

storage temp.:
2-8°C

SMILES string:
O=C(C(CC1)N(C2=O)C(C3=C2C=CC=C3NCCCN)=O)NC1=O.Cl

Img

Sigma Aldrich

911666

≥95%...


ligand:
pomalidomide

Assay:
≥95%

form:
powder

reaction suitability:
reactivity: carboxyl reactivereagent type: ligand-linker conjugate

functional group:
amine

storage temp.:
2-8°C

SMILES string:
O=C(C(CC1)N(C2=O)C(C3=C2C=CC=C3NCCCCCCN)=O)NC1=O.Cl

Img

Sigma Aldrich

911690

≥95%...


ligand:
C5 Lenalidomide

Assay:
≥95%

form:
powder

reaction suitability:
reagent type: ligand

functional group:
__

storage temp.:
2-8°C

SMILES string:
NC1=CC=C2C(CN(C3CCC(NC3=O)=O)C2=O)=C1

Img

Sigma Aldrich

911704

≥95%...


ligand:
C5 Lenalidomide

Assay:
≥95%

form:
powder or crystals

reaction suitability:
reactivity: carboxyl reactivereagent type: ligand-linker conjugate

functional group:
amine

storage temp.:
2-8°C

SMILES string:
O=C1N(C2CCC(NC2=O)=O)CC3=CC(NC(CCCN)=O)=CC=C31.Cl